Dr. Reddy's Laboratories Limited vs Arrowhead Pharmaceuticals, Inc.: Examining Key Revenue Metrics

Pharma Giants: A Decade of Revenue Evolution

__timestampArrowhead Pharmaceuticals, Inc.Dr. Reddy's Laboratories Limited
Wednesday, January 1, 2014175000132170000000
Thursday, January 1, 2015382000148189000000
Friday, January 1, 2016158333154708000000
Sunday, January 1, 201731407709140809000000
Monday, January 1, 201816142321142028000000
Tuesday, January 1, 2019168795577153851000000
Wednesday, January 1, 202087992066174600000000
Friday, January 1, 2021138287000189722000000
Saturday, January 1, 2022243231000214391000000
Sunday, January 1, 2023240735000245879000000
Monday, January 1, 20243551000279164000000
Loading chart...

Unlocking the unknown

A Tale of Two Pharmaceutical Giants: Revenue Trends from 2014 to 2024

In the ever-evolving pharmaceutical industry, Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc. have showcased contrasting revenue trajectories over the past decade. Dr. Reddy's, a stalwart in the industry, has consistently demonstrated robust growth, with revenues surging by approximately 111% from 2014 to 2024. This growth underscores its strategic prowess in capturing market share and expanding its global footprint.

Conversely, Arrowhead Pharmaceuticals, a dynamic player in the biotech sector, has experienced a more volatile revenue journey. Despite a staggering 1,300% increase in revenue from 2014 to 2023, the company faced fluctuations, reflecting the inherent risks and rewards of biotech innovation.

As we look to the future, these trends offer valuable insights into the strategic directions and market dynamics shaping the pharmaceutical landscape.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025